RUSSO, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 1.894
AS - Asia 1.502
EU - Europa 1.320
SA - Sud America 234
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 65
Totale 5.101
Nazione #
US - Stati Uniti d'America 1.831
SG - Singapore 469
CN - Cina 424
FI - Finlandia 273
IT - Italia 258
VN - Vietnam 257
DE - Germania 216
IE - Irlanda 188
BR - Brasile 183
SE - Svezia 171
HK - Hong Kong 82
BD - Bangladesh 72
FR - Francia 64
TR - Turchia 64
ZA - Sudafrica 52
GB - Regno Unito 37
NL - Olanda 31
CA - Canada 27
IN - India 23
AR - Argentina 21
CI - Costa d'Avorio 21
MX - Messico 19
UA - Ucraina 16
ID - Indonesia 15
BE - Belgio 14
JP - Giappone 14
IQ - Iraq 11
RU - Federazione Russa 11
TW - Taiwan 11
CZ - Repubblica Ceca 9
EC - Ecuador 9
PH - Filippine 8
JO - Giordania 7
KR - Corea 7
PK - Pakistan 7
TH - Thailandia 7
HU - Ungheria 6
LT - Lituania 6
MA - Marocco 6
VE - Venezuela 6
AZ - Azerbaigian 5
AT - Austria 4
BO - Bolivia 4
CO - Colombia 4
ES - Italia 4
UZ - Uzbekistan 4
CL - Cile 3
HR - Croazia 3
JM - Giamaica 3
PL - Polonia 3
SA - Arabia Saudita 3
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 5.036
Città #
Singapore 259
Ashburn 230
Chandler 191
Dublin 188
San Jose 153
Santa Clara 137
Munich 130
Ann Arbor 114
Parma 112
Beijing 111
Dallas 97
Ho Chi Minh City 79
Hong Kong 76
Helsinki 58
Hanoi 56
Boardman 53
Dearborn 51
Johannesburg 51
Council Bluffs 47
Izmir 47
Los Angeles 44
New York 43
Shanghai 41
Nanjing 39
Jacksonville 30
Princeton 28
Bremen 27
Lauterbourg 24
Wilmington 24
Abidjan 21
São Paulo 19
Columbus 16
Buffalo 15
Brussels 13
Kunming 13
Rio de Janeiro 13
Shenyang 13
Da Nang 12
Hebei 11
Hefei 11
Nanchang 11
Tokyo 11
Toronto 11
Düsseldorf 10
San Mateo 10
Turku 10
Washington 10
Guangzhou 9
Haiphong 9
Jakarta 9
Milan 9
Grafing 8
Hangzhou 8
Jinan 8
Kocaeli 8
Mexico City 8
Montreal 8
New Taipei City 8
Orem 8
Poplar 8
Seattle 8
Amman 7
Denver 7
London 7
Moscow 7
Rome 7
Springfield 7
Stockholm 7
Ankara 6
Brasília 6
Chennai 6
Chicago 6
Fremont 6
Houston 6
Jiaxing 6
Modena 6
Quito 6
San Francisco 6
The Dalles 6
Tianjin 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Brooklyn 5
Changsha 5
Frankfurt am Main 5
Fuzhou 5
Manchester 5
Prata Di Pordenone 5
Woodbridge 5
Atlanta 4
Boston 4
Can Tho 4
Des Moines 4
Hyderabad 4
Lubbock 4
Manaus 4
Nuremberg 4
Olomouc 4
Ottawa 4
Totale 3.098
Nome #
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey 327
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 248
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 231
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 225
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 224
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 221
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 212
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 212
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 209
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 192
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 187
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 178
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism 171
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 167
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 166
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 164
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 159
Mannich base derivatives as novel EGFR irreversible inhibitors 156
Structure activity relationship of new EphA2 ligands 154
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 154
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 154
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 151
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 150
Target-hopping: a useful approach to identify novel Eph receptor antagonists 146
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 143
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 137
Mechanical vibrations applied to nondestructive evaluation of materials and structures 117
Structure-activity realtionships of new EphaA2 ligands 107
Small-molecule modulators of receptor tyrosine kinases as potential antitumor agents 39
Totale 5.101
Categoria #
all - tutte 15.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 0 0 0 38 4 11 14 11 5 12 8 48
2022/2023668 75 84 25 53 70 75 12 36 219 4 13 2
2023/2024219 16 16 5 9 8 35 32 21 10 10 21 36
2024/2025897 27 50 50 53 92 104 108 56 111 56 68 122
2025/20261.794 158 172 155 157 233 115 176 58 278 134 87 71
2026/2027287 33 102 101 51 0 0 0 0 0 0 0 0
Totale 5.101